Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 158-162 , November 2006

Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer

  • Youngmin Choi

      Affiliations

    • Department of Radiation Oncology, and
    • Corresponding Author InformationCorresponding author. Youngmin Choi, Department of Radiation Oncology, College of Medicine, Dong-A University Hospital, 3-Ga-1 Dongdaesindong, Sugu, Busan 602-175, South Korea.
  • ,
  • Jeung-Kee Kim

      Affiliations

    • Department of Radiation Oncology, and
  • ,
  • Hyung-Sik Lee

      Affiliations

    • Department of Radiation Oncology, and
  • ,
  • Won-Joo Hur

      Affiliations

    • Department of Radiation Oncology, and
  • ,
  • Young-Seoub Hong

      Affiliations

    • Department of Preventive Medicine, College of Medicine, Dong-A University Hospital, Sugu, Busan, South Korea
  • ,
  • Sungkwang Park

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Inje University, Busan, South Korea
  • ,
  • Kijung Ahn

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Inje University, Busan, South Korea
  • ,
  • Heunglae Cho

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Inje University, Busan, South Korea

Received 16 January 2006 ,Revised 19 September 2006 ,Accepted 22 September 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(06)00487-7

doi: 10.1016/j.radonc.2006.09.010

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 158-162 , November 2006